About US
Contact us
-
GlaxoSmithKline Joins Fight Against Doping in SportUK-based pharmaceutical major GlaxoSmithKline has signed a long-term agreement with the World Anti-Doping Agency to help detect emerging performance-enhance drugs in sport. Under the agreement, th2011/7/6
-
US Rules Out Drug Data BanThe US will not ban the sale of prescription drug data collected by pharmacies to drug manufacturers, it has been ruled. The US Supreme Court voted 6-3 against the state of Vermont's legislation to2011/7/5
-
Pill for rare ageing disease on the horizonBy Dr Ananya Mandal, MD Scientists have found that a drug used in transplant patients could reverse the effects of premature ageing and extend human life by over 10 years. A team of US scientis2011/7/5
-
Pfizer Sues Indian Firm Over Lipitor Patent InfringementPfizer has sued India's Aurobindo Pharma over an alleged patent infringement of cholesterol lowering drug Lipitor. Lipitor is one of the best selling medications in the US market, with annual sales2011/7/4
-
Pill for rare ageing disease on the horizonBy Dr Ananya Mandal, MD Scientists have found that a drug used in transplant patients could reverse the effects of premature ageing and extend human life by over 10 years. A team of US scientis2011/7/4
-
Multinational drug companies' scamIn an Al Jazeera opinion piece, the first in a two-part series, Khadija Sharife, a journalist and visiting scholar at the Center for Civil Society, examines how multinational drug companies control ma2011/7/1
-
Research raises questions about some generic epilepsy drugsGeneric anti-epilepsy drugs, pharmaceutical products similar to brand-name versions, save consumers billions of dollars each year, but some are different enough from branded formulations that they may2011/7/1
-
SFDA held videoconference on implementing Provisions for Adverse Drug Reaction Reporting and MonitoringThe newly revised Provisions for Adverse Drug Reaction Reporting and Monitoring will come into effect on July 1, 2011. The State Food and Drug Administration (SFDA) held a videoconference for implemen2011/6/30
-
FDA looks at Avastin risksBy Dr Ananya Mandal, MD The US Food and Drug Administration is holding a two-day hearing that pits the FDA's Center for Drug Evaluation and Research against Genentech, that manufactures breast canc2011/6/30
-
Viewpoints: Calif.'s budget, Supreme Court drug rulings, the Avastin debateLos Angeles Times: California's Grand Budget Bargain That Wasn't The budget is not realistic, counting on fantastical revenue projections as well as a redevelopment gambit that's likely to be blocke2011/6/30